Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-344-0 | CAS number: 16215-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Relevant data are available to assess the skin and eye irritation potential of the target substance dibutyl peroxydicarbonate. In a primary dermal vitro irritation study conducted according to OECD guideline 439, the target substance showed no irritant effects. Contrasting results were obtained from a in vivo skin irritation study. As recommended in ECHA “Guidance on the Application of the CLP Criteria” the test design can only be used to apply the CLP criteria in case of negative results. By assessing the available data in a weight-of-evidence approach classification for skin irritation is not warranted based on the results of the OECD 439 guideline study.
In a primary eye irritation study conducted similar to OECD 405, 0.1 mL of the target substance was instilled into one eye of each of six New Zealand White Rabbits. Under the experimental conditions reported, the test substance showed only slight irritant effects in the eye of New Zealand White rabbits. Based on the results of the studies, the target substance can be considered non-irritant to the skin and eye.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-03-17 to 2017-05-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- This test uses the EPISKIN-SM™ reconstructed human epidermis model (SkinEthic) which consists of normal human epidermal keratinocytes (NHEK) and therefore represents in vitro the target organ of the species of interest and closely mimics the biochemical and physiological properties of the upper parts of the human skin, i.e. the epidermis.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN-SM™ (SkinEthic)
- Tissue batch number(s): 17-EKIN-014
SkinEthic Kit:
- EPISKIN-SM™ plate containing 12 reconstructed epidermis units (area: 0.38 cm²); each reconstructed epidermis is attached to the base of a tissue culture insert with an O-ring set and maintained on nutritive agar for transport (Lot No.: 17-EKIN-014):
1x 12-well assay plate
1x flask of sterile maintenance medium (basic medium for incubations, Lot No.: 17-MAIN3-013)
1x flask of sterile assay medium (basic medium for use in MTT assays, Lot No.: 17-ESSC-013)
- Validity controls as provided by the supplier (SkinEthic):
Morphology:
- Histology scoring (HES stained vertical paraffin sections, n=6):
Specification ≥ 19.5
Result: 22.3 ± 1.0, CV = 4.7 %
Well-differentiated epidermis consisting of a basal layer, several spinous and granular layers and a thick stratum corneum.
Barrier function:
- IC50 determination (SDS concentration, MTT test, n=14):
Specification 1.5 mg/mL < IC50 < 3 mg/mL
Result: 2.2 mg/mL
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: Room temperature
- Temperature of post-treatment incubation (if applicable): 37 ± 1 °C, 5.0 % CO2
REMOVAL OF TEST MATERIAL AND CONTROLS
- washed with DPBS
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 h
- Wavelength: 570 nm
- Filter bandwidth: ± 30 nm
NUMBER OF REPLICATE TISSUES: 3 tissues per dose group
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be irritant to skin if the viability after 15 minutes exposure and 42 h post-treatment incubation is less than or equal to 50%.
- The test substance is considered to be non-irritant to skin if the viability after 15 minutes exposure and 42 h post-treatment incubation is greater than 50%. - Control samples:
- yes, concurrent vehicle
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 µL (undiluted)
VEHICLE
- Amount(s) applied (volume or weight with unit): 10 µL DPBS
- Lot/batch no. (if required): Lot No.: 1838067
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 10 µL SDS solution
- Concentration (if solution): 5% - Duration of treatment / exposure:
- 15 min ± 0.5 miin
- Duration of post-treatment incubation (if applicable):
- 42 ± 1 h
- Number of replicates:
- 3 tissues per dose group
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean of three tissues
- Value:
- 69.1
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- For detailed results see "Any other information on results" Table 1
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study under the given conditions the test item showed no irritant effects. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.
- Executive summary:
In the present study the skin irritant potential of Dibutyl peroxydicarbonate was analysed according to OECD 439 using the EPISKIN-Standard Model™ (EPISKIN-SMTM), a reconstituted three-dimensional human epidermis model to distinguish between UN GHS “Category 2” skin irritating test substances and not categorized test substances (“No Category”) which may be considered as non-irritant. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 15 min exposure and 42 h post-incubation period and compared to those of the concurrent negative controls.
In this study under the given conditions the test item showed no irritant effects (69.1 % mean relative tissue viability). As the relative mean tissue viability after 15 min of exposure and 42 h post-incubation was > 50%, the test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.
Reference
Results of the Pre-Experiments
The mixture of 10 μL test item per 2 mL MTT medium showed no reduction of MTT as compared to the solvent. The mixture did not turn blue/purple. Therefore, NSMTT equalled 0%.
The mixtures of 10 μL of the test item per 90 μL aqua dest. and per 90 μL isopropanol showed no colouring detectable by unaided eye-assessment. Therefore, NSCliving equalled 0%.
Results of the main experiment
Table 1: Results of the test item
Name | Negative Control | Positive Control | Test Item | ||||||
Tissue | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
Absolute OD570 | 0.573 | 0.598 | 0.598 | 0.095 | 0.070 | 0.126 | 0.408 | 0.492 | 0.396 |
0.598 | 0.660 | 0.632 | 0.096 | 0.072 | 0.138 | 0.422 | 0.510 | 0.380 | |
OD570 (Blank corrected | 0.529 | 0.554 | 0.554 | 0.051 | 0.026 | 0.082 | 0.365 | 0.448 | 0.352 |
0.554 | 0.616 | 0.589 | 0.053 | 0.028 | 0.094 | 0.379 | 0.467 | 0.336 | |
Mean OD570 of the Duplicates (Blank corrected) | 0.542 | 0.585 | 0.571 | 0.052 | 0.027 | 0.088 | 0.372 | 0.457 | 0.344 |
Total Mean OD570 of 3 Replicate Tissues (Blank corrected) | 0.566* | 0.056 | 0.391 | ||||||
SD OD570 | 0.022 | 0.031 | 0.059 | ||||||
Relative Tissue Viabilities [%] | 95.7 | 103.4 | 100.9 | 9.2 | 4.8 | 15.5 | 65.7 | 80.8 | 60.8 |
Mean Relative Tissue Viabilities [%] | 100.0 | 9.8** | 69.1 | ||||||
SD Tissue Viabilities [%] | 3.9 | 5.4 | 10.4 | ||||||
CV [% Viability] | 3.9 | 55.0 | 15.1 |
* Corrected mean OD570 of the negative control corresponds to 100% absolute tissue viability.
** Mean relative tissue viability of the three positive control tissues is ≤ 40%.
Table 2: Test Acceptance Criteria
|
Value |
Cut off |
pass/fail |
Mean OD570 nmBlank |
0.044 |
< 0.1 |
pass |
Mean Absolute OD570 nmNK |
0.610 |
0.6 ≤ NK ≤1.5 |
pass |
Mean Relative Viability [%] PC |
9.8 |
≤ 40% |
pass |
Max. SD of % Viability [%] |
10.4 |
≤ 18% |
pass |
Table 3: Historical Data
OD570± 30 nmblank | Absolute OD570± 30 nm NK |
Relative Viability [%] PC | SD of Viability [%] | |
Mean | 0.043 | 0.839 | 11.3 | 7.8 |
SD | 0.002 | 0.128 | 7.8 | 14.1 |
n | 81 | 80 | 81 | 324 |
Historical control data were generated from 2008 – 2016.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- November 1976
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: FDA Fed. Reg. 28 (119), 5582, 1963
- Deviations:
- no
- GLP compliance:
- no
- Specific details on test material used for the study:
- - Name of the test material: Trigonox NBP-C 50 (di-n. butyl peroxydicarbonate)
- Appearance: liquid
- Purity: 50% solution in Shellsol T
- Storage condition of test material: stored at -20 ˚C until use - Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Housing: Animals are caged individually and receive no hay or extraneous material that might enter the eye - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL of the test substance - Duration of treatment / exposure:
- The test substance is applied to the uppler and lower eye lid, which are then carefully closed and subsequently held together for at least one second. The eyes are not washed following the application of the test material and the animals are released immediately.
- Observation period (in vivo):
- The eyes are examined at 24, 48, 72 h and 7 days after instillation of the test material.
- Number of animals or in vitro replicates:
- 6 per test material
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing: The eyes are not washed following the application of the test material and the animals are released immediately
SCORING SYSTEM:
- The test is considered positive if four or more of the animals in the test group of six rabbits exhibit a positive reaction
- If one animal exhibits a positive reaction, the test is regarded as negative
- If two or three animals exhibit a positive reaction, the test is repeated, using a different group of six animals.
- The second test is considered positive if three or more of the animals exhibit a positive reaction.
- If only one or two animals in the second test exhibit a positive reaction, the test is again repeated with a different group of six animals.
- If a third test is needed, the substance will be regarded as an irritant if two or more animals exhibit a püositive response.
TOOL USED TO ASSESS SCORE: binocular - Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- of six animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 2
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 4
- Reversibility:
- fully reversible within: 72 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0.33
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 0.667
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #5
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #6
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 7 days
- Remarks on result:
- probability of mild irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0.33
- Max. score:
- 3
- Reversibility:
- fully reversible within: 48 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 0.33
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 48 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #5
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #6
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 7 days
- Remarks on result:
- probability of mild irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- 6 animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- For detailed results please refer to Table 1 in box "Any other information on results incl tables".
- Other effects:
- - Lesions and clinical observations: The eye lesions caused by the test item was of a slight degree.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions reported, the test substance Trigonox NBP-C 50 showed only slight irritant effects in the eye of New Zealand White rabbits. Based on the results and in accordance with the CLP criteria, no classification is warranted.
- Executive summary:
In a primary eye irritation study conducted similar to OECD test guideline 405, 0.1 mL of Trigonox NBP-C 50 was instilled into the upper and lower eye lid of one eye of each of six New Zealand White rabbits. Animals were observed for a total of 7 days. Scoring was conducted 24 h, 48 h, 72 h and 7 days after test substance administration. Eye lesions were scored by the method of Draize. Only slight irritant effects were observed, which were fully reversible within 7 days at latest. Only in two animals a conjunctivae redness score of 1 was still recorded after 7 days. Based on the results and in accordance with the CLP criteria, no classification is warranted.
Reference
Table 1: Individual scores awarded to the ocular lesions elicited by Trigonox NBP-C 50
Animal No. |
Cornea |
Iris |
Conjunctivae |
|
Redness |
Chemosis |
|||
After 24 hours |
||||
1 |
0 |
0 |
2 |
3 |
2 |
0 |
0 |
1 |
1 |
3 |
0 |
0 |
1 |
1 |
4 |
0 |
0 |
1 |
0 |
5 |
0 |
0 |
1 |
0 |
6 |
0 |
0 |
>1 |
1 |
After 48 hours |
||||
1 |
0 |
0 |
1 |
1 |
2 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
0 |
4 |
0 |
0 |
0 |
0 |
5 |
0 |
0 |
1 |
0 |
6 |
0 |
0 |
1 |
1 |
After 72 hours |
||||
1 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
1 |
4 |
0 |
0 |
0 |
0 |
5 |
0 |
0 |
1 |
0 |
6 |
0 |
0 |
1 |
1 |
After 7 days |
||||
1 |
0 |
0 |
1 |
0 |
2 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
0 |
6 |
0 |
0 |
1 |
0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Relevant data are available to assess the skin and eye irritation potential of the target substance dibutyl peroxydicarbonate. In a primary dermal vitro irritation study conducted according to OECD guideline 439, the target substance showed no irritant effects. Contrasting results were obtained from a in vivo skin irritation study. As recommended in ECHA “Guidance on the Application of the CLP Criteria” the test design can only be used to apply the CLP criteria in case of negative results. By assessing the available data in a weight-of-evidence approach classification for skin irritation is not warranted based on the results of the OECD 439 guideline study.
In a primary eye irritation study conducted similar to OECD 405, 0.1 mL of the target substance was instilled into one eye of each of six New Zealand White Rabbits. Under the experimental conditions reported, the test substance showed only slight irritant effects in the eye of New Zealand White rabbits. Based on the results of the studies, the target substance can be considered non-irritant to the skin and eye.
Justification for classification or non-classification
Based on the available data, no classification for skin and/or eye irritation is warranted for the target substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)